Novel 3-Amino-6-chloro-7-(azol-2 or 5-yl)-1,1-dioxo-1,4,2-benzodithiazine Derivatives with Anticancer Activity: Synthesis and QSAR Study
作者:Aneta Pogorzelska、Jarosław Sławiński、Kamil Brożewicz、Szymon Ulenberg、Tomasz Bączek
DOI:10.3390/molecules201219821
日期:——
A series of new 3-amino-6-chloro-7-(azol-2 or 5-yl)-1,1-dioxo-1,4,2-benzodithiazine derivatives 5a–j have been synthesized and evaluated in vitro for their antiproliferative activity at the U.S. National Cancer Institute. The most active compound 5h showed significant cytotoxic effects against ovarian (OVCAR-3) and breast (MDA-MB-468) cancer (10% and 47% cancer cell death, respectively) as well as a good selectivity toward prostate (DU-145), colon (SW-620) and renal (TK-10) cancer cell lines. To obtain a deeper insight into the structure-activity relationships of the new compounds 5a–j QSAR studies have been applied. Theoretical calculations allowed the identification of molecular descriptors belonging to the RDF (RDF055p and RDF145m in the MOLT-4 and UO-31 QSAR models, respectively) and 3D-MorSE (Mor32m and Mor16e for MOLT-4 and UO-31 QSAR models) descriptor classes. Based on these data, QSAR models with good robustness and predictive ability have been obtained.
一系列新的 3-氨基-6-氯-7-(azol-2 或 5-yl)-1,1-二氧代-1,4,2-苯并二噻嗪衍生物 5a–j 已被合成并在体外评估美国国家癌症研究所的抗增殖活性。最活跃的化合物 5h 对卵巢癌 (OVCAR-3) 和乳腺癌 (MDA-MB-468) 表现出显着的细胞毒性作用(癌细胞死亡分别为 10% 和 47%),并对前列腺癌 (DU-145) 具有良好的选择性)、结肠(SW-620)和肾(TK-10)癌细胞系。为了更深入地了解新化合物 5a-j 的结构-活性关系,已经应用了 QSAR 研究。理论计算允许识别属于 RDF(分别在 MOLT-4 和 UO-31 QSAR 模型中的 RDF055p 和 RDF145m)和 3D-MorSE(MOLT-4 和 UO-31 QSAR 模型中的 Mor32m 和 Mor16e)描述符的分子描述符类。基于这些数据,获得了具有良好鲁棒性和预测能力的QSAR模型。